Abstract
The efficacy of microparticulate systems containing anticancer agents may be assessed in vitro prior to evaluation of the effects of targeted and controlled drug release on tumor growth. Particles prepared in a size range suitable for aerosol delivery to the lungs (1–5 μm) would be useful in the treatment of locally occurring tumors. Bovine serum albumin microparticles containing doxorubicin (2.6-μm median diameter) were prepared by an emulsion technique with thermal stabilization. Dialysis was used to assess drug release in citrate phosphate buffer pH 4.0 and phosphate buffer pH 7.4, at 37 °C. Sixty percent of the doxorubicin load was released in a 10-h burst at pH 4.0. An additional 20% was released up to 70 h. Fifty percent of the drug was released in 70 h at pH 7.4. S180 murine sarcoma cells were incubated with doxorubicin in solution and in microparticle suspension for 24, 48, and 72 h to evaluate cytotoxicity. Viable cells were recovered in smaller numbers following treatment with doxorubicin microparticles than following treatment with doxorubicin solution. The action of doxorubicin on growth of S180 murine sarcoma cells was enhanced in vitro by delivery in microparticles. A four-fold reduction in the effective dose, at which the rate of cell death exceeds replication, was observed for microparticles (5 μg/ml) than for doxorubicin alone (20 μg/ml). Therefore, the doxorubicin microparticles exhibit potential for greater therapeutic effect than drug alone when evaluated in vitro. Further studies are required to demonstrate the aerodynamic properties of these particles and efficacy in an in vivo tumor model.
Footnotes
- Copyright © Parenteral Drug Association. All rights reserved.
PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.
If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing.
Full issue PDFs are for PDA members only.
Note to pda.org users
The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.